The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prostate cancer incidence and disease-specific survival in men participating in the ERSPC with an initial PSA less than 3.0 ng/mL.
Meelan Bul
No relevant relationships to disclose
Pim J. van Leeuwen
No relevant relationships to disclose
Xiaoye Zhu
No relevant relationships to disclose
Fritz H. Schröder
No relevant relationships to disclose
Monique J. Roobol
No relevant relationships to disclose